Levodopa/benserazide
              < Levodopa 
 
            
          
| Combination of | |
|---|---|
| Levodopa | Dopamine agonist | 
| Benserazide | Decarboxylase inhibitors | 
| Clinical data | |
| Trade names | Prolopa, Madopar, others | 
| Pregnancy category | 
 | 
| Routes of administration | By mouth | 
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| KEGG | |
Levodopa/benserazide, sold under the brand name Prolopa among others, is a fixed-dose combination medication used for the treatment of Parkinson's disease.